Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia A Shekhar, WZ Potter, J Lightfoot, J Lienemann D Pharm, S Dubé, ... American Journal of Psychiatry 165 (8), 1033-1039, 2008 | 600 | 2008 |
Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction M Ayalew, H Le-Niculescu, DF Levey, N Jain, B Changala, SD Patel, ... Molecular psychiatry 17 (9), 887-905, 2012 | 466 | 2012 |
A key role for orexin in panic anxiety PL Johnson, W Truitt, SD Fitz, PE Minick, A Dietrich, S Sanghani, ... Nature medicine 16 (1), 111-115, 2010 | 453 | 2010 |
Regulation of anxiety by GABAA receptors in the rat amygdala SK Sanders, A Shekhar Pharmacology Biochemistry and Behavior 52 (4), 701-706, 1995 | 402 | 1995 |
Current perspectives of the roles of the central norepinephrine system in anxiety and depression AW Goddard, SG Ball, J Martinez, MJ Robinson, CR Yang, JM Russell, ... Depression and anxiety 27 (4), 339-350, 2010 | 387 | 2010 |
Modulation of anxiety circuits by serotonergic systems CA Lowry, PL Johnson, A Hay-Schmidt, J Mikkelsen, A Shekhar Stress 8 (4), 233-246, 2005 | 379 | 2005 |
Corticotrophin releasing factor-induced synaptic plasticity in the amygdala translates stress into emotional disorders DG Rainnie, R Bergeron, TJ Sajdyk, M Patil, DR Gehlert, A Shekhar Journal of Neuroscience 24 (14), 3471-3479, 2004 | 353 | 2004 |
Serotonergic systems, anxiety, and affective disorder: focus on the dorsomedial part of the dorsal raphe nucleus CA Lowry, MW Hale, AK Evans, J Heerkens, DR Staub, PJ Gasser, ... Annals of the New York Academy of Sciences 1148 (1), 86-94, 2008 | 334 | 2008 |
Role of stress, corticotrophin releasing factor (CRF) and amygdala plasticity in chronic anxiety A Shekhar, W Truitt, D Rainnie, T Sajdyk Stress 8 (4), 209-219, 2005 | 321 | 2005 |
Orexin, stress, and anxiety/panic states PL Johnson, A Molosh, SD Fitz, WA Truitt, A Shekhar Progress in brain research 198, 133-161, 2012 | 254 | 2012 |
Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca2+ channel complex JM Brittain, DB Duarte, SM Wilson, W Zhu, C Ballard, PL Johnson, N Liu, ... Nature medicine 17 (7), 822-829, 2011 | 253 | 2011 |
Interactions between NPY and CRF in the amygdala to regulate emotionality TJ Sajdyk, A Shekhar, DR Gehlert Neuropeptides 38 (4), 225-234, 2004 | 248 | 2004 |
Discovery and validation of blood biomarkers for suicidality H Le-Niculescu, DF Levey, M Ayalew, L Palmer, LM Gavrin, N Jain, ... Molecular psychiatry 18 (12), 1249-1264, 2013 | 241 | 2013 |
Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs JK Abrams, PL Johnson, A Hay-Schmidt, JD Mikkelsen, A Shekhar, ... Neuroscience 133 (4), 983-997, 2005 | 237 | 2005 |
Auditory event-related potential abnormalities in bipolar disorder and schizophrenia BF O'donnell, JL Vohs, WP Hetrick, CA Carroll, A Shekhar International Journal of Psychophysiology 53 (1), 45-55, 2004 | 237 | 2004 |
Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses TJ Sajdyk, DA Schober, DR Gehlert, A Shekhar Behavioural brain research 100 (1-2), 207-215, 1999 | 226 | 1999 |
Differential effects of exposure to low-light or high-light open-field on anxiety-related behaviors: relationship to c-Fos expression in serotonergic and non-serotonergic … JA Bouwknecht, F Spiga, DR Staub, MW Hale, A Shekhar, CA Lowry Brain research bulletin 72 (1), 32-43, 2007 | 219 | 2007 |
Brain imaging studies in mood and anxiety disorders: special emphasis on the amygdala A Anand, A Shekhar Annals of the New York Academy of Sciences 985 (1), 370-388, 2003 | 214 | 2003 |
Stress-related serotonergic systems: implications for symptomatology of anxiety and affective disorders MW Hale, A Shekhar, CA Lowry Cellular and molecular neurobiology 32, 695-708, 2012 | 211 | 2012 |
Multicenter, randomized, double‐blind, active comparator and placebo‐controlled trial of a corticotropin‐releasing factor receptor‐1 antagonist in generalized anxiety disorder V Coric, HH Feldman, DA Oren, A Shekhar, J Pultz, RC Dockens, X Wu, ... Depression and anxiety 27 (5), 417-425, 2010 | 202 | 2010 |